Aggregator
Daily briefing: Lung microbiome linked to a mysterious tissue-scarring condition
Science with military applications is cited more than civilian-only research
Babies’ birth weight improves with help of payments to parents
Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant
Device could sniff out fusion reactors secretly making material for a nuclear bomb
What’s behind China’s historically high counts of corresponding authors?
This mysterious lung disease affects millions of people — but a drug tested in mice shows promise
Long-range extended chains arising from polymerization-driven spontaneous assembly
Science, Ahead of Print.
Cancer’s favorite escape trick may actually make it easier to kill
Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology for decades. The research found that when cancer cells shut down a key immune-recognition molecule called MHC I—a common trick used to hide from “killer” T cells—they can actually become more vulnerable to attack by a different group of immune cells known as CD4+ “helper” T cells.
AI executives join call for stricter regulation of synthetic biology
Letter urges Congress to require DNA firms to screen orders to prevent AI-aided bioweapons
House spending panel proposes slight raise for NIH in 2027
Draft bill rejects Trump’s plan to slash and rejigger the $47 billion biomedical research agency
U.S. health agencies join fight against ‘ultraprocessed foods’—whatever they are
Some scientists criticize label as ambiguous and confusing; others call it a valuable lens on diet
Bees just did something no other insect has been shown to do
Like humans, bumble bees can plan ahead when working through a problem, even pausing to consider the solution
Amid a flood of AI advances, astrophysicists are questioning the soul of their field
Researchers see enormous power in new tools—but also the potential end of astrophysics as a human endeavor
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.
This new diabetes pill burns fat without the downsides of Ozempic
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated.
Scientists reverse anxiety by fixing a tiny brain circuit
A newly identified group of amygdala neurons appears to play a central role in anxiety and social behavior. Restoring normal activity in this tiny brain circuit reversed anxiety and social deficits in mice, revealing a promising new target for future treatments.
After empty promises, string theory finds new uses
Physicists hope back-to-basics approach could point toward alternative paths to “theory of everything”
Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities
Mitochondria are essential for neuronal energy production, cellular homeostasis, and overall neuronal function. Due to their high metabolic demands and limited regenerative capacity, neurons are particularly vulnerable to mitochondrial dysfunction, which leads to ATP depletion, excessive reactive oxygen species (ROS) production, and calcium imbalance-ultimately causing oxidative stress, metabolic disruption, and neuronal death. Mitophagy is a selective process that removes damaged mitochondria...
Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias
To better characterize the genetic architecture underlying Alzheimer's disease (AD) and related dementias (ADRD), we performed a meta-analysis of European-ancestry genome-wide association studies in 128,681 cases or proxy cases of ADRD and 849,833 (proxy) controls. We identified 91 genetic loci associated with ADRD risk, of which 16 are new and 56 are specifically detected in clinically diagnosed AD cases. We also provide a list of 18 loci (15 new) requiring further external validation. A...